Table 1. Association statistics for the 36 previously reported psoriasis susceptibility loci.
| SNP | Chr. | Position (bp) | Notable genes | Risk/non-risk allele | RAF (case) | RAF (control) | P-value | OR | Tsoi SNP | r2 Tsoi SNP |
|---|---|---|---|---|---|---|---|---|---|---|
| rs33980500 | 6 | 111,913,262 | TRAF3IP2 | T/C | 0.11 | 0.07 | 2.65E−16 | 1.6 | rs33980500 | 1 |
| rs4921482 | 5 | 158,764,478 | IL12B | ADRA1B | T/C | 0.74 | 0.67 | 1.47E−15 | 1.4 | rs4379175 | 0.85* |
| rs12044149 | 1 | 67,600,686 | IL23R | T/G | 0.32 | 0.25 | 2.25E−15 | 1.4 | rs9988642 | 0.14 |
| rs2020854 | 12 | 56,743,367 | STAT2 | T/C | 0.96 | 0.93 | 7.73E−10 | 1.7 | rs2066819 | 0.99 |
| rs34725611 | 19 | 10,477,067 | TYK2 | A/G | 0.76 | 0.71 | 2.99E−09 | 1.3 | rs34536443 | 0.09 |
| rs76956521 | 5 | 150,464,641 | TNIP1 | ANXA6 | C/A | 0.08 | 0.05 | 4.98E−09 | 1.5 | rs2233278 | 1 |
| rs4795067 | 17 | 26,106,675 | NOS2A | G/A | 0.39 | 0.34 | 1.94E−07 | 1.2 | rs28998802 | 0.06 |
| rs984971 | 2 | 163,224,521 | IFIH1 | T/G | 0.68 | 0.64 | 3.62E−06 | 1.2 | rs17716942 | 0.3 |
| rs7523412 | 1 | 25,294,264 | RUNX3 | SYF2 | A/G | 0.54 | 0.5 | 5.42E−06 | 1.2 | rs7536201 | 0.99 |
| rs848 | 5 | 131,996,500 | IL13 | C/A | 0.85 | 0.82 | 1.05E−05 | 1.2 | rs1295685 | 0.96 |
| rs7552167 | 1 | 24,518,643 | IL28RA | GRHL3 | G/A | 0.89 | 0.86 | 1.53E−05 | 1.3 | rs7552167 | 1 |
| rs6063454 | 20 | 48,590,791 | ZNF313 | SNAI1 | G/T | 0.63 | 0.59 | 2.90E−05 | 1.2 | rs1056198 | 0.9 |
| rs1306395 | 2 | 61,076,272 | PAPOLG | REL | T/C | 0.61 | 0.57 | 2.99E−05 | 1.2 | rs62149416 | 0.77 |
| rs1133071 | 9 | 32,455,674 | DDX58 | C/T | 0.34 | 0.3 | 3.36E−05 | 1.2 | rs11795343 | 0.18 |
| rs892085 | 19 | 10,818,092 | ILF3 | T/C | 0.59 | 0.55 | 4.02E−05 | 1.2 | rs892085 | 1 |
| rs2298428 | 22 | 21,982,892 | LOC150223 | T/C | 0.2 | 0.18 | 4.38E−05 | 1.2 | rs4821124 | 0.96 |
| rs6713082 | 2 | 62,516,544 | B3GNT2 | TMEM17 | A/C | 0.27 | 0.24 | 4.59E−05 | 1.2 | rs10865331 | 0.29 |
| rs8016947 | 14 | 35,832,666 | PSMA6 | LOC122589 | G/T | 0.6 | 0.56 | 9.65E−05 | 1.2 | rs8016947 | 1 |
| rs4796659 | 17 | 40,590,029 | PTRF | ATP6V0A1 | G/T | 0.93 | 0.91 | 0.000132 | 1.3 | rs963986 | 0.01 |
| rs62376445 | 5 | 96,196,721 | ERAP1 | ERAP2 | C/A | 0.96 | 0.94 | 0.000174 | 1.4 | rs27432 | 0.02 |
| rs610604 | 6 | 138,199,417 | TNFAIP3 | G/T | 0.35 | 0.32 | 0.000325 | 1.1 | rs582757 | 0.78 |
| rs7761186 | 6 | 512,951 | EXOC2 | LOC727827 | T/C | 0.99 | 0.98 | 0.000709 | 1.8 | rs9504361 | 0.01 |
| rs645078 | 11 | 64,135,298 | RPS6KA4 | A/C | 0.64 | 0.61 | 0.00086 | 1.1 | rs645078 | 1 |
| rs11121129 | 1 | 826,8095 | ERRFI1 | SLC45A1 | A/G | 0.33 | 0.3 | 0.000934 | 1.1 | rs11121129 | 1 |
| rs4936059 | 11 | 128,502,496 | ETS1 | FLI1 | G/A | 0.35 | 0.32 | 0.001475 | 1.1 | rs3802826 | 0 |
| rs12928822 | 16 | 11,403,893 | PRM1 | C16orf75 | C/T | 0.84 | 0.81 | 0.001593 | 1.2 | rs367569 | 0.56 |
| rs6693105 | 1 | 152,590,663 | LCE3B | LCE3A | C/T | 0.68 | 0.65 | 0.002892 | 1.1 | rs6677595 | 1 |
| rs7197717 | 16 | 31,083,075 | ZNF668 | C/A | 0.41 | 0.38 | 0.003544 | 1.1 | rs12445568 | 0.92 |
| rs4561177 | 11 | 109,962,432 | LOC260340 | ZC3H12C | A/G | 0.6 | 0.57 | 0.003782 | 1.1 | rs4561177 | 1 |
| rs73112675 | 7 | 37,379,030 | ELMO1 | G/A | 0.2 | 0.17 | 0.004116 | 1.1 | rs2700987 | 0.18 |
| rs602422 | 18 | 51,805,130 | POLI | C/T | 0.31 | 0.29 | 0.004767 | 1.1 | rs545979 | 1 |
| rs1972346 | 10 | 81,067,480 | ZMIZ1 | C/G | 0.61 | 0.59 | 0.008258 | 1.1 | rs1250546 | 0.4 |
| rs11652075 | 17 | 78,178,893 | CARD14 | C/T | 0.51 | 0.49 | 0.01423 | 1.1 | rs11652075 | 1 |
| rs1973919 | 6 | 159,440,727 | RSPH3 | TAGAP | C/T | 0.33 | 0.31 | 0.01812 | 1.1 | rs2451258 | 0.22 |
| rs12236285 | 9 | 110,855,243 | LOC392382 | A/G | 0.08 | 0.07 | 0.03838 | 1.2 | rs10979182 | 0.03 |
bp, base pair; Chr, chromosome; OR, odds ratio; RAF, risk allele frequency.
*Tsoi secondary effect.